No Evidence for Advanced Glycation Endproducts in Cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Kidney & Blood Pressure Research

• Publication date

  2007-08-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1159/000107091PMID 17700031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease?

  2007cited by this paper
• Genomic Damage and Malignancy in End-Stage Renal Failure: Do Advanced Glycation End Products Contribute?

  2006cited by this paper
• An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.

  2006cited by this paper
• Serum carboxymethyllysine predicts mortality in hemodialysis patients.

  2006cited by this paper
• Genotoxicity of Advanced Glycation End Products: Involvement of Oxidative Stress and of Angiotensin II Type 1 Receptors

  2005cited by this paper
• Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.

  2005cited by this paper
• Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress.

  2004cited by this paper
• Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients.

  2003cited by this paper
• Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.

  2003cited by this paper
• C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

  2002cited by this paper
• The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

  2002cited by this paper
• Advanced glycation end products and mortality in hemodialysis patients.

  2002cited by this paper

• No citing papers are available for this paper.